| Autor: |
Jacobs, Laurie M, Schmidt, Laura A, Schillinger, Dean, Schmidt, Jamey M, Alegria, Katie E, Parrett, Bethany, Pickett, Amanda, Epel, Elissa S |
| Předmět: |
|
| Zdroj: |
Public Health Nutrition; 2024, Vol. 27 Issue 1, p1-6, 6p |
| Abstrakt: |
Objective: Workplace sugar-sweetened beverage (SSB) sales bans can reduce SSB consumption. Because stress and anxiety can promote sugar consumption, we examined whether anxiety among hospital employees during the COVID-19 pandemic was associated with changes in SSB consumption and explored whether this relationship varied by exposure to a workplace SSB sales ban. Design: In a prospective, controlled trial of workplace SSB sales bans, we examined self-reported anxiety (generalised anxiety disorder-7) and self-reported SSB consumption (fluid ounces/d) before (July 2019) and during (May 2020) the COVID-19 pandemic. Setting: Hospital sites in two conditions (four with SSB sales bans and three without sales bans) in Northern California. Participants: We sampled 580 participants (hospital employees) from a larger trial of sales bans; all were regular consumers of SSB (minimum 3/week at main trial enrollment). This subsample was chosen based on having appropriately timed data for our study questions. Results: Across conditions, participants reduced SSB consumption over the study period. However, participants with higher pandemic-era anxiety scores experienced smaller reductions in SSB consumption after 9 months compared with those with lower anxiety scores (β = 0·65, P < 0·05). When the sample was disaggregated by sales ban condition, this relationship held for participants in the control group (access to SSB at work, β = 0·82, P < 0·05), but not for those exposed to an SSB sales ban (β = 0·42, P = 0·25). Conclusions: SSB sales bans likely reduce SSB consumption through multiple pathways; buffering stress-related consumption may be one mechanism. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
